News

August 16, 2010

A highly accurate, automated process for managing the genotyping of laboratory mice is headed to Bar Harbor, Maine. In response to the increased demand for using transgenic mouse models and the requisite genotyping of such animals, The Jackson Laboratory will be implementing a HighRes Biosolutions automated process to improve the maintenance of their extensive and diverse mouse colonies.

July 21, 2010

HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.

July 12, 2010

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it will be providing high-throughput screening automation to Rigel Pharmaceuticals, a South San Francisco, California-based clinical-stage drug development company.

Rigel will perform cell-based, biochemical, and high-content screening assays against a large library of compounds on a HighRes dual NanoCell system, which includes two of HighRes' AmbiStore high-speed carousels. The entire system is controlled by Cellario, HighRes' powerful dynamic scheduling software.

June 11, 2010

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that Andy Zaayenga, Director of Business Development, received the 2010 International Society for Biological and Environmental Repositories (ISBER) Special Service Award in recognition of his dedicated service and exceptional contributions to the organization. ISBER is the leading international society that addresses the technical, legal, ethical, and managerial issues relevant to repositories of biological and environmental specimens.

May 13, 2010

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it has joined the Standardization in Lab Automation (SiLA) consortium.

The SiLA consortium for Standardization in Lab Automation is developing new device and data interface standards, with the aim of allowing rapid integration of lab automation and data management systems. Leading system manufacturers, software suppliers, system integrators and pharmaceutical/biotech corporations form the SiLA consortium.

April 26, 2010

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it has hired Chris Pacheco, Ph.D, as Director of Life Science Technologies. Dr. Pacheco joins HighRes from Dr. Susan Lindquist’s lab at the Whitehead Institute for Biomedical Research at MIT.

December 21, 2009

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that industry veteran Andy Zaayenga has been hired as Director of Business Development. Andy’s appointment accompanies a period of consistent expansion for HighRes, including new offerings in sample management and increasing focus in biospecimen science.

June 22, 2009

HighRes Biosolutions, the leader in innovative robotic systems and laboratory devices for private and academic research laboratories, announced the launch of NanoCell, its newest entry into the world of modular robotic equipment used in drug discovery. NanoCell, the smallest modular work cell available, responds to the ever-increasing demand for a small, flexible, and dynamic system that can do all that HighRes’ larger MicroStar can do - but over a smaller footprint and on a much smaller budget.

September 2, 2008

(La Jolla, CA) - September 2, 2008 - Burnham Institute for Medical Research (Burnham) announced today that it has been awarded a prestigious six-year, $97.9 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health (NIH). Burnham will equip and manage one of four comprehensive small-molecule screening and discovery centers in the nation. Burnham was selected from among some of the nation’s largest and most prestigious universities and medical research institutions.

Pages